| Financial Year |
March 31 2023 |
| Monetary Funds |
278,015,254.58 |
| Held-for-trading Financial Assets |
50,060,100.00 |
| Notes Receivable |
16,955,506.25 |
| Accounts Receivable |
784,447,497.21 |
| Advances to Suppliers |
150,985,718.82 |
| Other Receivables |
61,420,475.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
793,386,472.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,196,175.65 |
| Other Current Assets |
91,999,220.51 |
| Total Current Assets |
2,520,804,969.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
437,935.58 |
| Long-term Equity Investment |
2,168,951.30 |
| Investment Properties |
206,462,658.00 |
| Fixed Assetes |
726,952,671.27 |
| Under-construction Projects |
5,073,730.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
225,822,650.96 |
| R&D expenses |
77,475,337.53 |
| Goodwill |
310,554,401.30 |
| Long-Term Deferred and Prepaid Expenses |
35,406,162.45 |
| Deferred Income Tax Assets |
103,358,186.16 |
| Other Non-Current Assets |
29,910,516.75 |
| Sub-Total of Non-Current Assets |
1,858,996,373.24 |
| Total Assets |
4,379,801,343.23 |
| Short-Term Loans |
813,854,200.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
131,152,379.38 |
| Accounts Payable |
312,897,165.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
81,219,514.94 |
| Taxes Payable |
21,518,348.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,163,084.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,226,902.29 |
| Other Current Liabilities |
111,142,703.53 |
| Sub-Total of Current Liabilities |
1,775,765,302.25 |
| Long-term Loans |
49,248,857.87 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,087,525.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
105,845,484.16 |
| Total Liabilities |
1,881,610,786.41 |
| Paid-In Capital(Or Share Stock) |
772,602,178.00 |
| Capital Surplus |
1,900,423,570.14 |
| Surplus Reserve |
53,782,993.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-293,248,378.76 |
| Minority Stockholder's Interest |
16,693,581.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,481,496,974.83 |
| Owner's Equity（Stockholder's Equity） |
2,498,190,556.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,379,801,343.23 |
